PTEN Loss/Mutation Is Associated with Hormone Receptor Loss during Breast Cancer Recurrence

被引：0
|
作者：
Zhan, Haiying [1 ]
Tang, Haiming [2 ]
Antony, Vijay [2 ]
Liang, Yuanxin [2 ]
Hui, Pei [2 ]
Krishnamurti, Uma [1 ]
DiGiovanna, Michael [3 ]
机构：
[1] Yale New Haven Hosp, Yale Sch Med, New Haven, CT USA
[2] Yale Univ, Sch Med, New Haven, CT USA
[3] Yale Canc Ctr, New Haven, CT USA
来源：
LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
265
引用
收藏
页码：S324 / S325
页数：2
相关论文
共 50 条
  • [31] Loss of Nuclear ARID-1A Expressions Is Associated with Hormone Receptor Status in Breast Cancers
    Uncel, Melek
    Diniz, Gulden
    Akoz, Gamze
    Ekin, Zubeyde Yildirim
    Sayhan, Sevil
    Yardim, Serdar
    Salimoglu, Semra
    EUROPEAN JOURNAL OF BREAST HEALTH, 2019, 15 (02) : 125 - 129
  • [32] PTEN loss is associated with aggressive behavior and poor prognosis in Middle Eastern Triple Negative Breast Cancer
    Siraj, Abdul K.
    Beg, Shaham
    Prabhakaran, Sarita
    Jehan, Zeenath
    Ajarim, Dahish
    Al-Dayel, Fouad
    Tulbah, Asma
    Al-Kuraya, Khawla
    CANCER RESEARCH, 2015, 75
  • [33] Bone loss associated with prevention of breast cancer
    Cauley, Jane A.
    LANCET ONCOLOGY, 2012, 13 (03): : 221 - 222
  • [34] Increased risk of local recurrence is associated with allelic loss in normal lobules of breast cancer patients
    Li, Z
    Moore, DH
    Meng, ZH
    Ljung, BM
    Gray, JW
    Dairkee, SH
    CANCER RESEARCH, 2002, 62 (04) : 1000 - 1003
  • [35] PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance
    Stern, Howard M.
    Gardner, Humphrey
    Burzykowski, Tomasz
    Elatre, Wafaa
    O'Brien, Carol
    Lackner, Mark R.
    Pestano, Gary A.
    Santiago, Angela
    Villalobos, Ivonne
    Eiermann, Wolfgang
    Pienkowski, Tadeusz
    Martin, Miguel
    Robert, Nicholas
    Crown, John
    Nuciforo, Paolo
    Bee, Valerie
    Mackey, John
    Slamon, Dennis J.
    Press, Michael F.
    CLINICAL CANCER RESEARCH, 2015, 21 (09) : 2065 - 2074
  • [36] Exploration of factors associated with imminent risk of late recurrence in hormone receptor positive breast cancer
    Jerzak, K. J.
    Cescon, D. W.
    Chia, S. K.
    Bratman, S.
    Ennis, M.
    Stambolic, V.
    Chang, M.
    Dowling, R.
    Goodwin, P. J.
    CANCER RESEARCH, 2019, 79 (04)
  • [37] Association of PTEN loss and local recurrence in stage II-III colon cancer
    Jiang, Z.
    Mehta, T. R.
    You, Y. N.
    Chang, G. J.
    Eng, C.
    Overman, M. J.
    Maru, D.
    Hamilton, S. R.
    Kopetz, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [38] Is PTEN loss associated with clinical outcome measures in human prostate cancer?
    McCall, P.
    Witton, C. J.
    Grimsley, S.
    Nielsen, K. V.
    Edwards, J.
    BRITISH JOURNAL OF CANCER, 2008, 99 (08) : 1296 - 1301
  • [39] PTEN gene loss, but not mutation, in benign and malignant phaeochromocytomas
    van Nederveen, F. H.
    Perren, A.
    Dannenberg, H.
    Petri, B-J
    Dinjens, W. N. M.
    Komminoth, P.
    De Krijger, R. R.
    JOURNAL OF PATHOLOGY, 2006, 209 (02): : 274 - 280
  • [40] Is PTEN loss associated with clinical outcome measures in human prostate cancer?
    P McCall
    C J Witton
    S Grimsley
    K V Nielsen
    J Edwards
    British Journal of Cancer, 2008, 99 : 1296 - 1301
12345